---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028873"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2022-10-19T23:59:59+00:00"
generated_at: "2026-06-23T02:45:19.456322+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TenX Keane Acquisition closes $66M IPO; $67.3M placed in trust for business combination

## Summary
- IPO of 6,600,000 units at $10/unit (including 600,000 over-allotment units) for gross proceeds of $66,000,000.
- Private placement of 394,000 placement units to sponsor at $10/unit, raising additional $3,940,000.
- Total $67,320,000 deposited into trust account for the benefit of public shareholders.
- Units trade on Nasdaq as TENKU; shares as TENK; rights as TENKR.
- Maxim Group LLC acted as sole book-running manager; IPO closed October 18, 2022.

## SEC filing metadata
- accession: 0001493152-22-028873
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2022-10-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000149315222028873/0001493152-22-028873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000149315222028873/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028873
- JSON: https://secwatch.observer/filing/0001493152-22-028873.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028873.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.